Immunotherapy for colorectal cancer: insight from inherited genetics-Reference-Cited by-同舟云学术

Immunotherapy for colorectal cancer: insight from inherited genetics

Published:2024-05 Issue:5 Volume:10 Page:444-456
ISSN:2405-8033
Container-title:Trends in Cancer
language:en
Short-container-title:Trends in Cancer

Author:

Tjader Nijole Pollock^ORCID,Toland Amanda Ewart

Funder

National Institutes of Health

National Cancer Institute

Pelotonia

Publisher

Elsevier BV

Reference84 articles.

1. Resistance mechanisms of anti-PD1/PDL1 therapy in solid tumors;Lei;Front. Cell Dev. Biol.,2020

2. CTLA4 tagging polymorphisms and risk of colorectal cancer: a case-control study involving 2,306 subjects;Zou;Onco Targets Ther.,2018

3. Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancers;Chalabi;Nat. Med.,2020

4. Durable clinical benefit with nivolumab plus ipilimumab in DNA mismatch repair-deficient/microsatellite instability-high metastatic colorectal cancer;Overman;J. Clin. Oncol.,2018

5. The prevalence and prognosis of microsatellite instability-high/mismatch repair-deficient colorectal adenocarcinomas in the United States;Gutierrez;JCO Precis. Oncol.,2023

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nuclear FAK aggravates CD8⁺T cell exhaustion via the SP1-IL-6 axis in colorectal cancer;2024-07-24

2. Exploring the Complexity and Promise of Tumor Immunotherapy in Drug Development;International Journal of Molecular Sciences;2024-06-11

3. Increased LACTB2 Expression Regulates Oxidative Phosphorylation and mTORC1 Signaling of Colorectal Cancer;Molecular Biotechnology;2024-04-25